EZH2 was highly expressed in breast cancer tissues (t = 9.236, P = 0.000), while DLC1 was expressed at low levels in breast cancer tissues (t = −3.238, P = 0.002) (Figure 2A). Here, DLC1 is linked to breast carcinoma.